Annual Meeting
The Annual Meeting of Stockholders will be held at 2 p.m., ET, on Tuesday,
April 22, 2008, at the Edward Nash Theatre at Raritan Valley Community College,
Route 28 and Lamington Road, North Branch, NJ.
Stock Trading Information
Merck stock is listed on the New York Stock Exchange (ticker symbol: MRK), the
Philadelphia Stock Exchange and the Paris Stock Exchange.
Direct Purchase of Merck Stock and Dividend Reinvestment Plan
You can purchase shares directly from the company through the Merck Stock
Investment Plan. Shares also may be purchased by automatic investment each
month. Merck’s Dividend Reinvestment Plan allows dividends (all or part) to be
automatically reinvested to purchase additional Merck shares. Call
800–522–9114, or write to:
Merck Stockholder Services, WS3AB–40
Merck & Co., Inc.
One Merck Drive, P.O. Box 100
Whitehouse Station, NJ 08889–0100
Stockholder Services
Call Monday through Friday, 8 a.m. to 8 p.m., ET, with questions on
stock–related matters, including verification of your holdings, to change your
address or to report lost or missing dividends. Call 800–522–9114, or write to
Merck Stockholder Services at the address listed above.
For Changes or Lost Stock Certificates
If you want to transfer your stock, change ownership or if you have lost your
stock certificates, call 800–522–9114, or write to:
Merck Shareowner Services
Wells Fargo Bank, N.A.
161 N. Concord Exchange
South St. Paul, MN 55075–1139
Independent Registered Public Accounting Firm
PricewaterhouseCoopers LLP
400 Campus Drive
Florham Park, NJ 07932
973–236–4000
News and Information
-
– News on Call
Access Merck news 24 hours a day, seven days a week by calling
800–CALL–MRK (800–225–5675).
-
– Investor Relations
Securities analysts and investment professionals with business–related
questions should call Investor Relations at 908–423–5881.
-
– Media Relations
Professional journalists should visit www.merck.com/newsroom for
contacts.
-
– Corporate Documents
Visit www.merck.com or write to: Merck Global Communications, WS1A–40
Merck & Co., Inc. One Merck Drive, P.O. Box 100 Whitehouse
Station, NJ 08889–0100 for copies of:
-
– Merck’s 2007 Form 10–K, as filed with the Securities and Exchange
Commission.
-
– Report on Diversity at Merck.
-
– Policies of the Board
(Merck governance principles).
-
– Merck Board Committee Charters – Audit, Compensation and Benefits,
Corporate Governance, Finance, Public Policy and Social
Responsibility, and Research.
-
– Merck’s Code of Conduct – Our Values and Standards.
Forward–Looking Statements
This report contains "forward–looking statements" as that term is
defined in the Private Securities Litigation Reform Act of 1995. These
statements are based on management’s current expectations and involve risks
and uncertainties, which may cause results to differ materially from those
set forth in the statements. The forward–looking statements may include
statements regarding product development, product potential or financial
performance. No forward–looking statement can be guaranteed, and actual
results may differ materially from those projected. Merck undertakes no
obligation to publicly update any forward–looking statement, whether as a
result of new information, future events, or otherwise. Forward–looking
statements in this report should be evaluated together with the many
uncertainties that affect Merck’s business, particularly those mentioned in
the risk factors and cautionary statements in Item 1A of Merck’s Form 10–K
for the year ended Dec. 31, 2007, and in its periodic reports on Form 10–Q
and Form 8–K, which the Company incorporates by reference.
Trademarks
All product or service marks appearing in type form different from that of
the surrounding text are trademarks or service marks owned by or licensed
to Merck & Co., Inc., its subsidiaries or affiliates. Cozaar
and Hyzaar are registered trademarks of E.I. du Pont de Nemours
and Company, Wilmington, Delaware, USA. Zetia and Vytorin
are trademarks owned by an entity of the Merck/Schering–Plough
Pharmaceuticals partnership.
Patient Assistance Programs
Merck offers several programs to give individuals greater access to the
medicines and vaccines they need. For more information, visit
www.merckhelps.com.
Corporate Responsibility at Merck
Information about corporate responsibility at Merck is available at
www.merck.com/cr.
The Merck Manuals
Merck publishes unbiased health information as a not–for–profit service
through The Merck Manuals, a collection of books designed to meet the needs
of health care professionals, caregivers and consumers. Books include
The Merck Manual, the world’s most widely used medical textbook;
The Merck Manual Second Home Edition, the world’s best–selling
home medical reference; The Merck Veterinary Manual; and
The Merck Index, an encyclopedia of chemicals, drugs and
biologicals. The newest manual, the Merck/Merial Manual for Pet
Health, was released in fall 2007 and is a complete health resource
for pet owners written in everyday language. It includes information on the
full spectrum of today’s pets, from dogs, cats and horses, to reptiles,
birds, fish and even exotic pets.
For more information on The Merck Manuals, and to access many of
them free online as part of Merck’s commitment to health, visit
www.merck.com.
